- Posts:
- 0 (N/A per day)
- Age:
- N/A
- Date Registered:
- Yesterday at 11:23:14
- Local Time:
- 2025-07-02, 01:18:58
- Last Active:
- Yesterday at 19:43:33
Signature:
A secondary screen of top hits in all three cell lines including PIK3CA-targeting drugs supports the utility of targeting the PI3K/AKT/mTOR pathway in